Amgen (AMGN): Rep. Kathy E. Manning (NC06) disclosed a purchase $1K–$15K
Rep. Kathy E. Manning (NC06) disclosed a purchase of Amgen in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 14 days
- Disclosure lag
- Traded
- Jul 27, 2022
- Disclosed
- Aug 10, 2022
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 4, 2021CongressDisclosed purchase of AMGN — reported range $15,001 - $50,000
- May 11, 2022CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
- Jul 20, 2022CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
- Jul 27, 2022 · this disclosureCongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
What came next
- Jul 27, 2022Congress · 1 personMembers of Congress: 2 sales
- Aug 3, 2022CongressDisclosed sale of AMGN — reported range $1,001 - $15,000
- Sep 26, 2022CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
- Oct 6, 2022CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
- Oct 12, 2022CongressDisclosed sale of AMGN — reported range $1,001 - $15,000
- Oct 19, 2022CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Amgen
For Amgen, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 54 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMGN page.
Other recent filings by Rep. Kathy E. Manning (NC06)
- House Clerk periodic transaction report at Pfizer (PFE)Sep 4, 2024
- House Clerk periodic transaction report at Starbucks (SBUX)Sep 4, 2024
- House Clerk periodic transaction report at Abbott Laboratories (ABT)Aug 16, 2024
- House Clerk periodic transaction report at Abbott Laboratories (ABT)Aug 16, 2024
- House Clerk periodic transaction report at AbbVie (ABBV)Aug 16, 2024
The full history of Rep. Kathy E. Manning (NC06) is on the profile page.
How this filing works
Explore the data
Other disclosures at Amgen
- House Clerk periodic transaction reportOct 1, 2026
- House Clerk periodic transaction reportSep 5, 2026
- House Clerk periodic transaction reportSep 5, 2026
- Senate eFD periodic transaction reportSep 2, 2026
- SEC Form 13F-HRAug 26, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its AMGN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
